Clinical Trial Update: A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia [Phase 3]

View source ↗

Summary

Phase III trial evaluating Z-338 in pediatric functional dyspepsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Z-338

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED